FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2045207629> ?p ?o ?g. }

• W2045207629 endingPage "826" @default.
• W2045207629 startingPage "814" @default.
• W2045207629 abstract "Amyotrophic lateral sclerosis is a neurodegenerative disorder characterized by progressive weakness, muscle atrophy, and paralysis due to the loss of upper and lower motoneurons (MNs). Sigma-1 receptor (sigma-1R) activation promotes neuroprotection after ischemic and traumatic injuries to the central nervous system. We recently reported that sigma-1R agonist (PRE-084) improves the survival of MNs after root avulsion injury in rats. Moreover, a mutation of the sigma-1R leading to frontotemporal lobar degeneration/amyotrophic lateral sclerosis (ALS) was recently described in human patients. In the present study, we analyzed the potential therapeutic effect of the sigma-1R agonist (PRE-084) in the SOD1(G93A) mouse model of ALS. Mice were daily administered with PRE-084 (0.25 mg/kg) from 8 to 16 weeks of age. Functional outcome was assessed by electrophysiological tests and computerized analysis of locomotion. Histological, immunohistochemical analyses and Western blot of the spinal cord were performed. PRE-084 administration from 8 weeks of age improved the function of MNs, which was manifested by maintenance of the amplitude of muscle action potentials and locomotor behavior, and preserved neuromuscular connections and MNs in the spinal cord. Moreover, it extended survival in both female and male mice by more than 15 %. Delayed administration of PRE-084 from 12 weeks of age also significantly improved functional outcome and preservation of the MNs. There was an induction of protein kinase C-specific phosphorylation of the NR1 subunit of the N-methyl-D-aspartate (NMDA) receptor in SOD1(G93A) animals, and a reduction of the microglial reactivity compared with untreated mice. PRE-084 exerts a dual therapeutic contribution, modulating NMDA Ca(2+) influx to protect MNs, and the microglial reactivity to ameliorate the MN environment. In conclusion, sigma-1R agonists, such as PRE-084, may be promising candidates for a therapeutical strategy of ALS." @default.
• W2045207629 created "2016-06-24" @default.
• W2045207629 creator A5013121748 @default.
• W2045207629 creator A5033497698 @default.
• W2045207629 creator A5047511050 @default.
• W2045207629 creator A5070885799 @default.
• W2045207629 creator A5075889230 @default.
• W2045207629 creator A5080751235 @default.
• W2045207629 date "2012-08-31" @default.
• W2045207629 modified "2023-10-01" @default.
• W2045207629 title "Sigma-1R Agonist Improves Motor Function and Motoneuron Survival in ALS Mice" @default.
• W2045207629 cites W1505473665 @default.
• W2045207629 cites W1960651454 @default.
• W2045207629 cites W1963565483 @default.
• W2045207629 cites W1969569152 @default.
• W2045207629 cites W1970433280 @default.
• W2045207629 cites W1973967631 @default.
• W2045207629 cites W1974795836 @default.
• W2045207629 cites W1978626709 @default.
• W2045207629 cites W1978909649 @default.
• W2045207629 cites W1979837223 @default.
• W2045207629 cites W1980904145 @default.
• W2045207629 cites W1986418241 @default.
• W2045207629 cites W1987210736 @default.
• W2045207629 cites W1990711213 @default.
• W2045207629 cites W1992064492 @default.
• W2045207629 cites W1992572137 @default.
• W2045207629 cites W1995552213 @default.
• W2045207629 cites W1995831624 @default.
• W2045207629 cites W2000775111 @default.
• W2045207629 cites W2004626052 @default.
• W2045207629 cites W2006238771 @default.
• W2045207629 cites W2010685508 @default.
• W2045207629 cites W2019079031 @default.
• W2045207629 cites W2026667906 @default.
• W2045207629 cites W2027047473 @default.
• W2045207629 cites W2040754808 @default.
• W2045207629 cites W2040891140 @default.
• W2045207629 cites W2049168135 @default.
• W2045207629 cites W2052332287 @default.
• W2045207629 cites W2053086684 @default.
• W2045207629 cites W2059195318 @default.
• W2045207629 cites W2059355164 @default.
• W2045207629 cites W2068201081 @default.
• W2045207629 cites W2070243481 @default.
• W2045207629 cites W2072413533 @default.
• W2045207629 cites W2084263537 @default.
• W2045207629 cites W2085656073 @default.
• W2045207629 cites W2093810274 @default.
• W2045207629 cites W2099677747 @default.
• W2045207629 cites W2110328115 @default.
• W2045207629 cites W2113663369 @default.
• W2045207629 cites W2125716259 @default.
• W2045207629 cites W2126912196 @default.
• W2045207629 cites W2128815118 @default.
• W2045207629 cites W2155611657 @default.
• W2045207629 cites W2157076525 @default.
• W2045207629 cites W2158649743 @default.
• W2045207629 cites W2158988264 @default.
• W2045207629 cites W4253140965 @default.
• W2045207629 cites W4295135156 @default.
• W2045207629 doi "https://doi.org/10.1007/s13311-012-0140-y" @default.
• W2045207629 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3480575" @default.
• W2045207629 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22935988" @default.
• W2045207629 hasPublicationYear "2012" @default.
• W2045207629 type Work @default.
• W2045207629 sameAs 2045207629 @default.
• W2045207629 citedByCount "139" @default.
• W2045207629 countsByYear W20452076292012 @default.
• W2045207629 countsByYear W20452076292013 @default.
• W2045207629 countsByYear W20452076292014 @default.
• W2045207629 countsByYear W20452076292015 @default.
• W2045207629 countsByYear W20452076292016 @default.
• W2045207629 countsByYear W20452076292017 @default.
• W2045207629 countsByYear W20452076292018 @default.
• W2045207629 countsByYear W20452076292019 @default.
• W2045207629 countsByYear W20452076292020 @default.
• W2045207629 countsByYear W20452076292021 @default.
• W2045207629 countsByYear W20452076292022 @default.
• W2045207629 countsByYear W20452076292023 @default.
• W2045207629 crossrefType "journal-article" @default.
• W2045207629 hasAuthorship W2045207629A5013121748 @default.
• W2045207629 hasAuthorship W2045207629A5033497698 @default.
• W2045207629 hasAuthorship W2045207629A5047511050 @default.
• W2045207629 hasAuthorship W2045207629A5070885799 @default.
• W2045207629 hasAuthorship W2045207629A5075889230 @default.
• W2045207629 hasAuthorship W2045207629A5080751235 @default.
• W2045207629 hasBestOaLocation W20452076292 @default.
• W2045207629 hasConcept C126322002 @default.
• W2045207629 hasConcept C134018914 @default.
• W2045207629 hasConcept C169760540 @default.
• W2045207629 hasConcept C170493617 @default.
• W2045207629 hasConcept C25498285 @default.
• W2045207629 hasConcept C2776752467 @default.
• W2045207629 hasConcept C2778938600 @default.
• W2045207629 hasConcept C2779134260 @default.
• W2045207629 hasConcept C2780596555 @default.
• W2045207629 hasConcept C2780775167 @default.

• next